R&D Centerresearch center
Research & development system of Credit Pharmaceutical is a technical research & development platform which takes enterprise as main body, market as orientation, production workshop as base, combines production, study and research, integrates research, experiment, development, introduction and technical transformation, and makes full use of the various advantageous resources, to develop the personnel benefits.
Credit Pharmaceutical aims to become an excellent world-famous Chinese pharmaceutical enterprise and also a product leader in the central nervous field of China.
The Company is mainly devoted to the research & development, production and sales of products in mind, nerve and pain, three major fields, and it is an honest and law-abiding demonstration enterprise of Sichuan Province.
Product implies the idea and also the culture. We use the most unique and therapeutic products to satisfy the market demands for nerve, mind and pain disease drugs.
CreditABOUT US See detail +
Founded in 2000, the company is located in Luzhou National High-tech Zone Pharmaceutical Industrial Park, covering an area of 260 mu, with more than 1000 employees. The company has four subsidiaries: Sino-US joint venture Sichuan Credit Kaihua Pharmaceutical Co., Ltd., Sichuan zhongling chuangtuo Pharmaceutical Co., Ltd., Federrid Biopharmaceutical (USA) Co., Ltd. and Sichuan Credit Median Medical Devices Co., Ltd. Since 2014, the company has successively become the No. 1 taxpayer for industrial enterprises in Luxian, the top 10 in Luzhou. In 2018, the company realized sales revenue of 660 million yuan and tax revenue exceeded 100 million yuan.
Focus on research and development, production and marketing of products in three major areas: spirit, nerve and pain
To become an excellent world-famous Chinese pharmaceutical enterprise and also a product leader in the central nervous field of China